1-153810180-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020699.4(GATAD2B):āc.1779A>Gā(p.Lys593=) variant causes a synonymous change. The variant allele was found at a frequency of 0.000000687 in 1,456,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 6.9e-7 ( 0 hom. )
Consequence
GATAD2B
NM_020699.4 synonymous
NM_020699.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.94
Genes affected
GATAD2B (HGNC:30778): (GATA zinc finger domain containing 2B) This gene encodes a zinc finger protein transcriptional repressor. The encoded protein is part of the methyl-CpG-binding protein-1 complex, which represses gene expression by deacetylating methylated nucleosomes. Mutations in this gene are linked to intellectual disability and dysmorphic features associated with cognitive disability. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GATAD2B | NM_020699.4 | c.1779A>G | p.Lys593= | synonymous_variant | 11/11 | ENST00000368655.5 | |
GATAD2B | XM_047426115.1 | c.1782A>G | p.Lys594= | synonymous_variant | 11/11 | ||
GATAD2B | XM_047426117.1 | c.1779A>G | p.Lys593= | synonymous_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GATAD2B | ENST00000368655.5 | c.1779A>G | p.Lys593= | synonymous_variant | 11/11 | 1 | NM_020699.4 | P1 | |
GATAD2B | ENST00000634544.1 | c.1779A>G | p.Lys593= | synonymous_variant | 11/11 | 5 | P1 | ||
GATAD2B | ENST00000634408.1 | c.1731A>G | p.Lys577= | synonymous_variant | 11/11 | 5 | |||
GATAD2B | ENST00000637918.1 | c.135+1551A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1456490Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 724282
GnomAD4 exome
AF:
AC:
1
AN:
1456490
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
724282
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 02, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with GATAD2B-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 593 of the GATAD2B mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the GATAD2B protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at